Literature DB >> 12055393

Malignant pleural effusions: treatment with tunneled long-term drainage catheters.

Jeffrey S Pollak1.   

Abstract

Malignant pleural effusion is a significant cause of morbidity and a poor prognostic indicator. Traditional treatments have variable success and significant drawbacks, including a length of stay in the hospital. Alternatively, a tunneled pleural catheter permits long-term drainage as an outpatient, cost-effectively controlling the effusion and related symptoms in over 80 to 90% of patients. Other advantages are the ability to treat trapped lungs and large locules. Spontaneous pleurodesis may occur in over 40% of patients, and the catheter can be used to administer sclerosant or antineoplastic agents. Complications tend to be minor and easily managed. A tunneled pleural catheter should be considered for all patients with MPE having a reasonable expectancy of being an outpatient.

Entities:  

Mesh:

Year:  2002        PMID: 12055393     DOI: 10.1097/00063198-200207000-00010

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  6 in total

1.  Effectiveness of tunneled pleural catheter placement in patients with malignant pleural effusions.

Authors:  Sangita Sudharshan; Victor A Ferraris; Timothy Mullett; Chandrashekhar Ramaiah
Journal:  Int J Angiol       Date:  2011-03

2.  Management of pleural effusion, empyema, and lung abscess.

Authors:  Hyeon Yu
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

3.  Percutaneous management of malignant fluid collections.

Authors:  Leann S Stokes
Journal:  Semin Intervent Radiol       Date:  2007-12       Impact factor: 1.513

4.  Successful use of central venous catheters in the management of recurrent malignant pleural effusions: one new option.

Authors:  Abbas Yazdanbod; Azita Salehifar; Nasrollah Maleki; Shahram Habibzadeh; Zahra Tavosi
Journal:  Support Care Cancer       Date:  2015-01-10       Impact factor: 3.603

5.  The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial.

Authors:  Rahul Bhatnagar; Brennan C Kahan; Anna J Morley; Emma K Keenan; Robert F Miller; Najib M Rahman; Nick A Maskell
Journal:  Trials       Date:  2015-02-12       Impact factor: 2.279

6.  Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction.

Authors:  Inderdeep Dhaliwal; Masoud Mahdavian; Shabnam Asghari; Benson Chun To Wong; Rosalie Labelle; Kayvan Amjadi
Journal:  Can Respir J       Date:  2016-12-15       Impact factor: 2.409

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.